What Is Ubrelvy? Uses, Dosage, and What You Need to Know in 2026

If you or someone you care for has recently been prescribed Ubrelvy — or your doctor mentioned it as a treatment option — this guide covers everything you need to know. Ubrelvy is one of the newest classes of migraine medication available, and it works very differently from older treatments like triptans or pain relievers.

What Is Ubrelvy?

Ubrelvy is a brand-name prescription medication. Its generic (active ingredient) name is ubrogepant. It belongs to a newer class of drugs called CGRP receptor antagonists, also known as "gepants." Ubrelvy was FDA-approved on December 23, 2019, making it the first oral CGRP antagonist approved for the acute treatment of migraine.

Ubrelvy is manufactured by AbbVie (originally developed and approved under Allergan). No generic version is currently available, and one is not expected until at least 2035.

What Is Ubrelvy Used For?

Ubrelvy is FDA-approved for one specific use: the acute treatment of migraine with or without aura in adults. "Acute treatment" means it's taken when a migraine attack occurs — at the first sign of symptoms — not taken daily to prevent attacks. Ubrelvy is not approved for migraine prevention.

A migraine aura refers to sensory symptoms (like visual disturbances, tingling, or speech difficulties) that occur before or during a migraine headache. Ubrelvy works regardless of whether aura is present.

Ubrelvy is not approved for children under 18. Its safety in pediatric patients has not been established.

How Does Ubrelvy Work?

During a migraine attack, the brain releases a protein called calcitonin gene-related peptide (CGRP). CGRP binds to receptors on nerve endings and triggers inflammation, blood vessel dilation, and pain signaling — all of which contribute to migraine symptoms.

Ubrelvy blocks the CGRP receptor, preventing CGRP from attaching and triggering these processes. By cutting off this signaling pathway, it reduces headache pain, nausea, and sensitivity to light and sound. Critically, Ubrelvy does NOT constrict blood vessels — making it an option for patients who can't safely use triptans.

Ubrelvy Dosage: How to Take It

Ubrelvy comes as oral tablets in two strengths: 50 mg and 100 mg. The tablets are white to off-white, capsule-shaped, individually packaged in unit-dose packets.

Recommended dose: 50 mg or 100 mg taken by mouth as needed, with or without food

Second dose: If your first dose doesn't work, you may take a second dose at least 2 hours after the initial dose

Maximum dose: 200 mg in any 24-hour period

Monthly limit: The safety of treating more than 8 migraines in a 30-day period has not been established

Timing: Can be taken at the first sign of migraine symptoms, even before head pain begins

If you're on certain medications (moderate CYP3A4 inhibitors like verapamil or diltiazem), your doctor will prescribe a lower dose (50 mg max per day). If you're on medications that reduce Ubrelvy's effectiveness (CYP3A4 inducers), a dose increase may be appropriate.

Is Ubrelvy a Controlled Substance?

No. Ubrelvy is not a narcotic, not an opioid, and not a controlled substance. It has no addiction or abuse potential. It does not have DEA scheduling. You do not need a special prescription format and there are no restrictions on refills beyond standard prescription policies.

How Does Ubrelvy Compare to Other Migraine Medications?

vs. Triptans (sumatriptan, rizatriptan): Triptans work by constricting blood vessels; Ubrelvy does not. Ubrelvy is safer for patients with cardiovascular disease. Triptans are available as cheap generics ($10–$40); Ubrelvy costs $1,100+ per month brand-only.

vs. Nurtec ODT (rimegepant): Same CGRP class. Nurtec is also approved for prevention (every other day use). Ubrelvy allows re-dosing after 2 hours; Nurtec does not. Both are brand-only with similar pricing.

vs. NSAIDs (ibuprofen, naproxen): NSAIDs are less targeted and less effective for severe migraines. They're inexpensive and OTC, making them useful for mild attacks.

How Much Does Ubrelvy Cost?

The wholesale list price for a 30-day supply of Ubrelvy is $1,139.09 as of January 2026. Retail cash price for 10 tablets ranges from approximately $1,300 to $1,450, depending on the pharmacy and dose. With insurance, your copay depends on your plan tier and prior authorization status.

The Ubrelvy Complete Savings Card (for commercially insured patients) can reduce monthly cost to as little as $0. See our full savings guide: How to Save Money on Ubrelvy in 2026.

Is Ubrelvy Right for You?

Ubrelvy is a strong option for adults with migraine (with or without aura) who want an effective, non-vasoconstrictive treatment that can be taken anytime, anywhere. Talk to your doctor if you've had unsatisfactory results with triptans, if you have cardiovascular concerns, or if you want a medication without a controlled substance status. And once you have a prescription, use medfinder to find a pharmacy near you that has it in stock.